Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003641
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
1999-11-01
Brief Title:
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Eastern Cooperative Oncology Group